MacuCLEAR, Inc.
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase II/III Study of the Efficacy and Safety of MacuCLEAR MC-1101 in Treating DryAge-Related Macular Degeneration (NCT02127463) | MacuCLEAR, Inc. | 2014-04-01 |
| Safety Study of a Topical Treatment for Dry Age Related Macular Degeneration (NCT01922128) | MacuCLEAR, Inc. | 2013-09-01 |
| Efficacy and Safety Study of MC-1101 1% TID in the Treatment of Nonexudative Age-Related Macular Degeneration (NCT01601483) | MacuCLEAR, Inc. | 2012-10-01 |
| A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD (NCT01013376) | MacuCLEAR, Inc. | 2009-08-01 |
Track MacuCLEAR, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.